Anemia predicts mortality in severe heart failure
Open Access
- 3 June 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 41 (11), 1933-1939
- https://doi.org/10.1016/s0735-1097(03)00425-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Anemia and Renal Insufficiency Are Independent Risk Factors for Death among Patients with Congestive Heart Failure Admitted to Community HospitalsJournal of the American Society of Nephrology, 2002
- Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failureJournal of the American College of Cardiology, 2002
- Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunctionJournal of the American College of Cardiology, 2001
- The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled studyJournal of the American College of Cardiology, 2001
- The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsJournal of the American College of Cardiology, 2000
- Effect of amlodipine on mode of death among patients with advanced heart failure in the praise trialThe American Journal of Cardiology, 1998
- Trends in hospitalization and mortality for heart failure in Spain, 1980-1993European Heart Journal, 1997
- Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1996
- Trends in hospitalization for heart failure in Scotland 1980-1990European Heart Journal, 1993
- Epidemiology and prevention of cardiac failure: Framingham Study insightsEuropean Heart Journal, 1987